MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
28.46
-0.50 (-1.73%)
Mar 26, 2026, 12:59 PM EDT - Market open
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $1.35 billion as of March 26, 2026. Its market cap has increased by 340.28% in one year.
Market Cap
1.35B
Enterprise Value
1.00B
1-Year Change
340.28%
Ranking
Category
Stock Price
$28.46
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has increased from $509.66M to $1.35B, an increase of 165.30%. That is a compound annual growth rate of 89.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 1.38B | -2.85% |
| Dec 31, 2025 | 1.42B | 129.95% |
| Dec 31, 2024 | 615.88M | 20.84% |
| Sep 13, 2024 | 509.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Damora Therapeutics | 1.44B |
| Nanobiotix | 1.43B |
| Pharvaris | 1.39B |
| Palvella Therapeutics | 1.38B |
| Trevi Therapeutics | 1.37B |
| Rapport Therapeutics | 1.35B |
| Ardelyx | 1.31B |
| Biohaven | 1.26B |